Mission

EndHIV (or Abzyme Research Foundation) is dedicated to advancing the HIV vaccine candidate of Dr. Sudhir Paul to a FDA Phase I human trial in 2011. With the help of University of Texas and TRCares.org we are aiming to raise, $1,000,000.00 in 2011 with your help.

What We Do

ARF supports crucial HIV vaccine research at the University of Texas and across the country exploring the potential of abzymes (antibody enzymes) as a path towards the world's first effective HIV vaccine.

To combat AIDS fatigue, and engage a new generation of advocates ARF is dedicated to connecting donors concerned with HIV/AIDS with an opportunity to make a measurable and succinct impact by advancing a viable therapeutic HIV vaccine candidate into human trials. Also, by producing innovative and challenging media we hope to connect with the most at risk youth populations and reinvigorate the conversation around HIV/AIDS.